Dolomite Bio, part of the Blacktrace group, is helping to drive forward the single cell genomics revolution. Single cell analysis promises to transform drug discovery and disease research, enabling scientists to investigate cell diversity and quantify gene expression at the cellular level.
Dolomite Bio, a leading provider of single cell technology, today launched a high throughput single nuclei RNA sequencing (sNuc-Seq) protocol for its Nadia Instrument. This latest addition to the Nadia application portfolio enables researchers to cost-effectively profile both complex and archived tissues.
Dolomite Bio, a leading provider of high throughput single cell technology today announced the release of its new drop-seq datasets for single cell RNA-Seq. The data, generated on Dolomite Bio’s Nadia Instrument, demonstrates excellent single cell RNA-seq performance with high gene capture, low doublet rates and cost-effective profiling.
Scientists in the Center for Neural Circuits and Behaviour at the University of Oxford have adopted Dolomite Bio’s RNA-Seq System to support their research into cell diversity in fruit fly (Drosophila) brains.
Dolomite Bio, a leading provider of high throughput single cell technology, and Partek Incorporated, a recognized leader in the development of powerful genomic data analysis tools – today announced a collaboration to combine Partek’s single cell data analysis capabilities with Dolomite Bio’s microfluidic droplet-based single cell technology.